PNC Financial Services Group
TMBR

PNC Financial Services Group’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

PNC Financial Services Group’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4
Closed -$8 – 4912
2022
Q4 		$8 Buy
+4
New +$10 ﹤0.01% 4752

Other funds holding TMBR

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

PNC Financial Services Group's TMBR Position: Q1 2023 in Review

PNC Financial Services Group sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q1 2023, closing a stake of 4 shares — an estimated $8 sold.

PNC Financial Services Group first reported a position in TMBR in Q4 2022 and held it in 1 quarter. The position peaked at $8 in Q4 2022. 13 funds tracked by Wall St. Rank hold TMBR as of Q1 2023.

  • PNC Financial Services Group reported no remaining Timber Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 4 Timber Pharmaceuticals, Inc. shares in Q1 2023, an estimated $8.
  • PNC Financial Services Group first reported a position in Timber Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • PNC Financial Services Group's Timber Pharmaceuticals, Inc. position peaked at $8 in Q4 2022.
  • 13 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.